1.      Batton B, Li L, Newman NS, et al; Eunice Kennedy Shriver National Institute of Child Health & Human Development Neonatal Research Network. Use of antihypotensive therapies in extremely preterm infants. Pediatrics. 2013;131(6):e1865–e1873

2.      Beaulieu MJ. Vasopressin for the treatment of neonatal hypotension. Neonatal Netw. 2013;32(2):120–124

3.      Chang AC, Atz AM,Wernovsky G, Burke RP,Wessel DL.Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med. 1995;23(11):1907–1914

4.      Dasgupta S, Jain SK, Aly AM. Neonatal hypotension, the role of hydrocortisone and other pharmacological agents in its management. J Pediatr Child Care. 2016;2(1):8

5.      Durrmeyer X, Marchand-Martin L, Porcher R, Gascoin G, Roze JC, Storme L, e  al. Abstention or intervention for isolated hypotension in the first 3 days of life in extremely preterm infants: association with short-term outcomes in the EPIPAGE 2 cohort study. Arch Dis Child Fetal Neonatal Ed 2017; 102:490e6.

6.      Dyke PC II, Tobias JD. Vasopressin: applications in clinical practice. J Intensive Care Med. 2004;19(4):220–228

7.      Evans K. Cardiovascular transition of the extremely prematüre infant and challenges to maintain hemodynamic stability. J Perinat Neonatal Nurs. 2016;30(1):68–72

8.      Fanaroff JM, Fanaroff AA. Blood pressure disorders in the neonate: hypotension and hypertension. Semin Fetal Neonatal Med. 2006;11 (3):174–181

9.      Fernandez EF, Watterberg KL. Relative adrenal insufficiency in the preterm and term infant. J Perinatol. 2009;29(suppl 2):S44–S49

10.  Gaissmaier RE, Pohlandt F. Single-dose dexamethasone treatment of hypotension in preterm infants. J Pediatr. 1999;134(6):701–705

11.  Giesinger RE, McNamara PJ. Hemodynamic instability in the critically ill neonate: an approach to cardiovascular support based on disease pathophysiology. Semin Perinatol. 2016;40(3):174–188

12.  Goldstein RF, Thompson RJ Jr, Oehler JM, Brazy JE. Influence of acidosis, hypoxemia, and hypotension on neurodevelopmental outcome in very low birth weight infants. Pediatrics. 1995;95(2):238–243

13.  Greisen G. Autoregulation of cerebral blood flow in newborn babies. Early Hum Dev. 2005;81(5):423–428Cayabyab R, McLean CW, Seri I. Definition of hypotension and assessment of hemodynamics in the preterm neonate. J Perinatol. 2009;29(suppl 2):S58–S62

14.  Ibrahim H, Sinha IP, Subhedar NV. Corticosteroids for treating hypotension in preterm infants. Cochrane Database Syst Rev. 2011;(12):CD003662

15.  Johnson PJ. Hydrocortisone for treatment of hypotension in the newborn. Neonatal Netw. 2015;34(1):46–51 49. Noori S, Siassi B, Durand M, Acherman R, Sardesai S, Ramanathan R. Cardiovascular effects of low-dose dexamethasone in very low birthweight neonates with refractory hypotension. Biol Neonate. 2006;89(2):82–87

16.  Klarr JM, Faix RG, Pryce CJ, Bhatt-Mehta V. Randomized, blind trial of dopamine versus dobutamine for treatment of hypotension in preterm infants with respiratory distress syndrome. J Pediatr. 1994;125(1):117–122

17.  Kluckow M. Low systemic blood flow and pathophysiology of the preterm transitional circulation. Early Hum Dev. 2005;81 (5):429–437

18.  Kluckow, M., & Seri, I. (2023). Cardiovascular compromise in the preterm infant during the first postnatal day. Neonatology Questions and Controversies: Neonatal Hemodynamics-E-Book, 399.

19.  Korte C, Styne D, Merritt TA, Mayes D, Wertz A, Helbock HJ. Adrenocortical function in the very low birth weight infant: improved testing sensitivity and association with neonatal outcome. J Pediatr. 1996;128(2):257–263

20.  Laughon M, Bose C, Allred E, et al.: Factors associated with treatment for hypotension in extremely low gestational age newborns during the first postnatal week, Pediatrics 119(2):273–280, 2007.

21.  Laughon M, Bose C, Clark R: Treatment strategies to prevent or close a patent ductus arteriosus in preterm infants and outcomes, J Perinatol 27(3):164–170, 2007.

22.  Laughon MM, Simmons MA, Bose CL. Patency of the ductus arteriosus in the premature infant: is it pathologic? Should it be treated? Curr Opin Pediatr. 2004;16(2):146–151

23.  Martinez AM, Padbury JF, Thio S. Dobutamine pharmacokinetics and cardiovascular responses in critically ill neonates. Pediatrics. 1992;89(1):47–51

24.  McNamara PJ, Shivananda SP, Sahni M, Freeman D, Taddio A. Pharmacology of milrinone in neonates with persistent pulmonary hypertension of the newborn and suboptimal response to inhaled nitric oxide. Pediatr Crit Care Med. 2013;14(1):74–84

25.  Meek JH, Tyszczuk L, Elwell CE, Wyatt JS. Low cerebral blood flow is a risk factor for severe intraventricular haemorrhage. Arch Dis Child Fetal Neonatal Ed. 1999;81(1):F15–F18

26.  Munro MJ, Walker AM, Barfield CP. Hypotensive extremely low birth weight infants have reduced cerebral blood flow. Pediatrics 2004;114:1591e6.

27.  Noori S, Friedlich P, Wong P, Ebrahimi M, Siassi B, Seri I. Hemodynamic changes after low-dosage hydrocortisone administration in vasopressor-treated preterm and term neonates. Pediatrics. 2006;118(4):1456–1466

28.  Noori S, McLean CW, Wu TW, Seri I. Cerebral circulation and hypotension in the premature infant: diagnosis and treatment. In: Perlman JM, Cilio MR, eds. Neurology: Neonatology Questions and Controversies. 3rd ed. Philadelphia: Elsevier; 2019:1–26.

29.  Noori S, Seri I. Evidence-based versus pathophysiology-based approach to diagnosis and treatment of neonatal cardiovascular compromise. Semin Fetal Neonatal Med 2015;20:238e45.

30.  Noori S, Seri I. Neonatal blood pressure support: the use of inotropes, lusitropes, and other vasopressor agents. Clin Perinatol. 2012;39(1):221–238

31.  Nuntnarumit P, Yang W, Bada-Ellzey HS. Blood pressure measurements in the newborn. Clin Perinatol 1999;26:981e96.

32.  O’Shea TM, Kothadia JM, Klinepeter KL, et al. Randomized placebocontrolled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: outcome of study participants at 1-year adjusted age. Pediatrics. 1999;104(1 Pt 1):15–21

33.  Paradisis M, Evans N, Kluckow M, Osborn D. Randomized trial of milrinone versus placebo for prevention of low systemic blood flow in very preterm infants. J Pediatr. 2009;154(2):189–195

34.  Price JF. Unique aspects of heart failure in the neonate. In: Shaddy RE, ed.Heart Failure in CongenitalHeart Disease: From Fetus to Adult. New York, NY: Springer; 2010:21–42

35.  Rios DR, Kaiser JR. Vasopressin versus dopamine for treatment of hypotension in extremely low birth weight infants: a randomized, blinded pilot study. J Pediatr. 2015;166(4):850–855

36.  Rios DR, Moffett BS, Kaiser JR: Trends in pharmacotherapy for neonatal hypotension, J Pediatr 165(4):697–701.e1, 2014.

37.  Sahni M, Jain SK. Role of the renin-angiotensin-aldosterone system in the management of neonatal heart failure. Neoreviews. 2015;16 (10):e575–e585

38.  Samiee-Zafarghandy S, Raman SR, van den Anker JN, et al; Best Pharmaceuticals for Children Act—Pediatric Trials Network Administrative Core Committee. Safety of milrinone use in neonatal intensive care units. Early Hum Dev. 2015;91(1):31–35

39.  Sawyer, Taylor, and Christine A. Gleason, eds. Avery's Diseases of the Newborn-E-Book. Elsevier Health Sciences, 2023.

40.  Schmaltz C. Hypotension and shock in the preterm neonate. Adv Neonatal Care. 2009;9(4):156–162

41.  Seri I. Circulatory support of the sick preterm infant. Semin Neonatol. 2001;6(1):85–95

42.  Shahab Noori PF, Seri I. The use of dobutamine in the treatment of neonatal cardiovascular compromise. NeoReviews. 2004;5(1):e22–e26

43.  Shead SL. Pathophysiology of the cardiovascular system and neonatal hypotension. Neonatal Netw. 2015;34(1):31–39

44.  So KW, Fok TF, Ng PC, Wong WW, Cheung KL. Randomised controlled trial of colloid or crystalloid in hypotensive preterm infants. Arch Dis Child Fetal Neonatal Ed. 1997;76(1):F43–F46

45.  Stark AR, Carlo WA, Tyson JE, et al; National Institute of Child Health and Human Development Neonatal Research Network. Adverse effects of early dexamethasone in extremely-low-birthweight infants. N Engl J Med. 2001;344(2):95–101

46.  Stranak Z, Semberova J, Barrington K, et al.: International survey on diagnosis and management of hypotension in extremely preterm babies, Eur J Pediatr 173(6):793–798, 2014.Kluckow M, Evans N: Superior vena cava flow in newborn infants: a novel marker of systemic blood flow, Arch Dis Child Fetal Neonatal Ed 82(3):F182–F187, 2000.

47.  Subhedar NV, Duffy K, Ibrahim H. Corticosteroids for treating hypotension in preterm infants. Cochrane Database Syst Rev. 2007; (1):CD003662

48.  Subhedar NV, Shaw NJ. Dopamine versus dobutamine for hypotensive preterm infants. Cochrane Database Syst Rev. 2003; (3): CD001242

49.  Subhedar NV. Treatment of hypotension in newborns. Semin Neonatol. 2003;8(6):413–423

50.  Valverde E, Pellicer A, Madero R, Elorza D, Quero J, Cabañas F. Dopamine versus epinephrine for cardiovascular support in low birth weight infants: analysis of systemic effects and neonatal clinical outcomes. Pediatrics. 2006;117(6):e1213–e1222

51.  Vargo L, Seri I. New NANN Practice Guideline: the management of hypotension in the very-low-birth-weight infant. Adv Neonatal Care. 2011;11(4):272–278

52.  Vrancken SL, van Heijst AF, de Boode WP. Neonatal hemodynamics: from developmental physiology to comprehensive monitoring. Front Pediatr. 2018;6:87. https://doi.org/10.3389/fped.2018.00087.

53.  Wu T-W, Azhibekov T, Seri I. Transitional hemodynamics in preterm neonates: clinical relevance. Pediatr Neonatol. 2016;57(1):7–18